세계의 DNA 및 유전자 칩 시장 : 제품 유형, 어레이 유형, 용도, 최종 사용자별예측(2025-2030년)

The DNA & Gene Chip Market was valued at USD 8.77 billion in 2023, expected to reach USD 9.71 billion in 2024, and is projected to grow at a CAGR of 11.34%, to USD 18.61 billion by 2030.

The DNA and Gene Chip market represents a specialized segment within the biotechnology and genomics field, focusing on technology facilitating the rapid analysis of gene expression and genetic variations. These chips, also called microarrays, are indispensable tools for advancing personalized medicine, diagnostics, and therapeutic development. Their necessity lies in enabling large-scale genomic research, accelerating drug discovery, and enhancing disease understanding. Applications span across oncology, pharmacogenomics, genetic analysis, and agricultural biotechnology, serving a wide range of end-users, including research labs, hospitals, and biopharmaceutical companies. The market is predominantly driven by the increasing demand for personalized medicine, technological advancements leading to cost-effective and high-throughput capabilities, and the expanding biotech industry. Furthermore, the rise in genetic disorders and cancer cases necessitates efficient diagnostic tools, providing potential growth opportunities.

However, certain growth barriers include the high costs associated with technology and data management challenges due to the vast amount of information generated. Intellectual property issues also present obstacles. Opportunities for tapping into emerging markets, enhancing data analysis techniques, and integrating artificial intelligence present significant avenues for growth. Companies should focus on developing affordable and user-friendly microarray solutions to cater to small and medium-sized enterprises. Moreover, expanding applications in agriculture for crop improvement and animal genetics could open new revenue streams.

For innovation, investing in platform development that simplifies data interpretation and enhances accuracy will be key. Moreover, research could focus on combining microarray technology with CRISPR and next-generation sequencing for improved diagnostics and treatment strategies. Understanding the competitive landscape, marked by rapid technological shifts and stringent regulatory policies, can aid businesses in strategically positioning themselves in the market. With a robust growth outlook, the DNA and Gene Chip market holds substantial potential, but companies need to effectively address challenges and leverage technological advancements to capitalize on emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving DNA & Gene Chip Market

The DNA & Gene Chip Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing need of DNA & gene chip for genetic analysis and diagnostics
  • Surging adoption of personalized medicines for cancer treatments
  • Increase in the demand for early cancer detection and cancer diagnosis
• Market Restraints
  • Lack of skilled and experienced subject experts
• Market Opportunities
  • Emerging miniaturization of DNA & gene chip
  • Strategic government fundings and initiatives for DNA & gene chip
• Market Challenges
  • Concern associated with gene expression regulation and availability of alternative technologies

Porter's Five Forces: A Strategic Tool for Navigating the DNA & Gene Chip Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the DNA & Gene Chip Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the DNA & Gene Chip Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the DNA & Gene Chip Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the DNA & Gene Chip Market

A detailed market share analysis in the DNA & Gene Chip Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the DNA & Gene Chip Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the DNA & Gene Chip Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the DNA & Gene Chip Market

A strategic analysis of the DNA & Gene Chip Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the DNA & Gene Chip Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Agilent Technologies, Inc., Arrayit Corporation, Biomerieux SA, Bioneer Corporation, CapitalBio Technology Co., Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Greiner Bio-One International GmbH, Illumina, Inc., Integrated Dna Technologies, LifeGen Technologies, LLC, Macrogen Inc., Merck KGaA, Microarrays Inc., Ocimum Biosolutions Ltd., Perkin Elmer, Inc., Promega Corporation, Savyon Diagnostics, Scienion AG by a Bico Company, Shanghai Biochip Co Ltd., Sophia Genetics SA, Surmodics Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Veritas Genetics, Inc..

Market Segmentation & Coverage

This research report categorizes the DNA & Gene Chip Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Instruments.
• Based on Array Type, market is studied across cDNA-Based Microarray and Oligonucleotide-Based Microarray.
• Based on Application, market is studied across Diagnostics, Drug Discovery & Development, Genomics, and Personalized Medicine.
• Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Clinical Laboratories, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing need of DNA & gene chip for genetic analysis and diagnostics
    • 5.1.1.2. Surging adoption of personalized medicines for cancer treatments
    • 5.1.1.3. Increase in the demand for early cancer detection and cancer diagnosis
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled and experienced subject experts
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging miniaturization of DNA & gene chip
    • 5.1.3.2. Strategic government fundings and initiatives for DNA & gene chip
  • 5.1.4. Challenges
    • 5.1.4.1. Concern associated with gene expression regulation and availability of alternative technologies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. DNA & Gene Chip Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Instruments

7. DNA & Gene Chip Market, by Array Type

• 7.1. Introduction
• 7.2. cDNA-Based Microarray
• 7.3. Oligonucleotide-Based Microarray

8. DNA & Gene Chip Market, by Application

• 8.1. Introduction
• 8.2. Diagnostics
• 8.3. Drug Discovery & Development
• 8.4. Genomics
• 8.5. Personalized Medicine

9. DNA & Gene Chip Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Hospitals & Clinical Laboratories
• 9.4. Pharmaceutical & Biotechnology Companies

10. Americas DNA & Gene Chip Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific DNA & Gene Chip Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa DNA & Gene Chip Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 23andMe, Inc.
• 2. Agilent Technologies, Inc.
• 3. Arrayit Corporation
• 4. Biomerieux SA
• 5. Bioneer Corporation
• 6. CapitalBio Technology Co., Ltd.
• 7. Eurofins Scientific SE
• 8. F. Hoffmann-La Roche AG
• 9. Greiner Bio-One International GmbH
• 10. Illumina, Inc.
• 11. Integrated Dna Technologies
• 12. LifeGen Technologies, LLC
• 13. Macrogen Inc.
• 14. Merck KGaA
• 15. Microarrays Inc.
• 16. Ocimum Biosolutions Ltd.
• 17. Perkin Elmer, Inc.
• 18. Promega Corporation
• 19. Savyon Diagnostics
• 20. Scienion AG by a Bico Company
• 21. Shanghai Biochip Co Ltd.
• 22. Sophia Genetics SA
• 23. Surmodics Inc.
• 24. Sysmex Corporation
• 25. Thermo Fisher Scientific Inc.
• 26. Twist Bioscience Corporation
• 27. Veritas Genetics, Inc.